These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23679245)

  • 21. Prognostic value of MMP-9 in ovarian cancer: a meta-analysis.
    Li LN; Zhou X; Gu Y; Yan J
    Asian Pac J Cancer Prev; 2013; 14(7):4107-13. PubMed ID: 23991961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological and prognostic significance of thyroid transcription factor-1 expression in small cell lung cancer: A systemic review and meta-analysis.
    Wang Y; Wu Y; Li J; Li J; Che G
    Pathol Res Pract; 2019 Dec; 215(12):152706. PubMed ID: 31704153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of tumor-derived and stromal-derived matrix metalloproteinase 2 predicted prognosis of ovarian cancer.
    Fu Z; Xu S; Xu Y; Ma J; Li J; Xu P
    Int J Gynecol Cancer; 2015 Mar; 25(3):356-62. PubMed ID: 25695542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: A meta-analysis of PSM studies.
    Ye F; Yu P; Li N; Yang A; Xie X; Tang H; Liu P
    Breast; 2020 Jun; 51():11-20. PubMed ID: 32172190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.
    Qi XW; Zhang F; Wu H; Liu JL; Zong BG; Xu C; Jiang J
    Sci Rep; 2015 Mar; 5():8924. PubMed ID: 25748047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
    Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
    Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma: A meta-analysis of 16 studies.
    Zhou J; Liu T; Wang W
    Medicine (Baltimore); 2018 Nov; 97(44):e13051. PubMed ID: 30383677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis.
    Wu Y; Zhang N; Yang Q
    BMC Cancer; 2017 Dec; 17(1):839. PubMed ID: 29228910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
    Li Y; Liu X; Zhang J; Yao W
    Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diagnostic and prognostic value of exosome-derived long non-coding RNAs in cancer patients: a meta-analysis.
    Mu H; Zhang S; Yao Z; Liu Y; Lin K; Zhao Z; Zhu Y
    Clin Exp Med; 2020 Aug; 20(3):339-348. PubMed ID: 32504320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between miR-200 Family Overexpression and Cancer Prognosis.
    Liu W; Zhang K; Wei P; Hu Y; Peng Y; Fang X; He G; Wu L; Chao M; Wang J
    Dis Markers; 2018; 2018():6071826. PubMed ID: 30069274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis.
    Cui M; Dong H; Duan W; Wang X; Liu Y; Shi L; Zhang B
    PeerJ; 2024; 12():e16958. PubMed ID: 38410801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic role of Twist or Snail in various carcinomas: a systematic review and meta-analysis.
    Zhang P; Hu P; Shen H; Yu J; Liu Q; Du J
    Eur J Clin Invest; 2014 Nov; 44(11):1072-94. PubMed ID: 25257753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis.
    Yang Y; Wu K; Liu Y; Shi L; Tao K; Wang G
    Medicine (Baltimore); 2017 Nov; 96(46):e8690. PubMed ID: 29145305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
    Zhang B; Xie Z; Li B
    Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronic acid predicts poor prognosis in breast cancer patients: A protocol for systematic review and meta analysis.
    Wu W; Chen L; Wang Y; Jin J; Xie X; Zhang J
    Medicine (Baltimore); 2020 May; 99(22):e20438. PubMed ID: 32481447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis.
    Liu C
    Clin Exp Med; 2016 Aug; 16(3):375-82. PubMed ID: 26123901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCNB2 expression correlates with worse outcomes in breast cancer patients: a pooled analysis.
    Sun C; Lowe S; Ma S; Bentley R; Zhou Z; Cheng C; Zhou Q
    Women Health; 2022 Aug; 62(7):655-663. PubMed ID: 35892137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer.
    Peng WJ; Zhang JQ; Wang BX; Pan HF; Lu MM; Wang J
    Clin Chim Acta; 2012 Jul; 413(13-14):1121-6. PubMed ID: 22465234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.